Enhancing natural killer cells is beneficial in multiple sclerosis

Abstract

Get full access to this article

View all access options for this article.

References

Laroni

Enhancing natural killer cells is beneficial in multiple sclerosis – Yes. Mult Scler 2019; 25: 510–512.

Liu

Shi

F-D

. Enhancing natural killer cells is beneficial in multiple sclerosis – No. Mult Scler 2019; 25: 512–513.

Benczur

Petranyl

Palffy

et al . Dysfunction of natural killer cells in multiple sclerosis: A possible pathogenetic factor. Clin Exp Immunol 1980; 39: 657–662.

Hauser

Ault

Levin

et al . Natural killer cell activity in multiple sclerosis. J Immunol 1981; 127: 1114–1117.

Zhang

Yamamura

Kondo

et al . Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells. J Exp Med 1997; 186: 1677–1687.

Matsumoto

Kohyama

Aikawa

et al . Role of natural killer cells and TCR gamma delta T cells in acute autoimmune encephalomyelitis. Eur J Immunol 1998; 28: 1681–1688.

Bielekova

Catalfamo

Reichert-Scrivner

et al . Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis. Proc Natl Acad Sci U S A 2006; 103: 5941–5946.

Jiang

Han

et al . Acetylcholine-producing NK cells attenuate CNS inflammation via modulation of infiltrating monocytes/macrophages. Proc Natl Acad Sci U S A 2017; 114: E6202–E6211.

Chong

van Panhuys

Chen

et al . NK-DC crosstalk controls the autopathogenic Th17 response through an innate IFN-γ-IL-27 axis. J Exp Med 2015; 212: 1739–1752.

10.

Elkins

Sheridan

Amaravadi

et al . CD56(bright) natural killer cells and response to daclizumab HYP in relapsing-remitting MS. Neurol Neuroimmunol Neuroinflamm 2015; 2: e65.

11.

Smith

Calabresi

Bhargava

Dimethyl fumarate treatment alters NK cell function in multiple sclerosis. Eur J Immunol 2018; 48: 380–383.

12.

Gross

Ahmetspahic

Ruck

et al . Alemtuzumab treatment alters circulating innate immune cells in multiple sclerosis. Neurol Neuroimmunol Neuroinflamm 2016; 3: e289.

13.

Darlington

Stopnicki

Touil

et al . Natural killer cells regulate Th17 cells after autologous hematopoietic stem cell transplantation for relapsing remitting multiple sclerosis. Front Immunol 2018; 9: 834.

14.

Peng

Tian

Diversity of tissue-resident NK cells. Semin Immunol 2017; 31: 3–10.

15.

Tahrali

Kucuksezer

Altintas

et al . Dysfunction of CD3^–CD16⁺CD56^dim and CD3^–CD16^–CD56^bright NK cell subsets in RR-MS patients. Clin Immunol 2018; 193: 88–97.

16.

Liu

Sanai

Jin

et al . Neural stem cells sustain natural killer cells that dictate recovery from brain inflammation. Nat Neurosci 2016; 19: 243–252.

17.

Lagumersindez-Denis

Wrzos

Mack

et al . Differential contribution of immune effector mechanisms to cortical demyelination in multiple sclerosis. Acta Neuropathol 2017; 134: 15–34.

Enhancing natural killer cells is beneficial in multiple sclerosis – Commentary

Abstract

Get full access to this article

References